These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8610387)

  • 1. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
    Soderberg C; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):594-600. PubMed ID: 8610387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
    Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
    Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of human cytomegalovirus by human CD13-specific antibodies.
    Giugni TD; Söderberg C; Ham DJ; Bautista RM; Hedlund KO; Möller E; Zaia JA
    J Infect Dis; 1996 May; 173(5):1062-71. PubMed ID: 8627055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission.
    Larsson S; Söderberg-Nauclér C; Möller E
    Transplantation; 1998 Feb; 65(3):411-5. PubMed ID: 9484762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.
    Rahbar A; Boström L; Söderberg-Naucler C
    J Autoimmun; 2006 May; 26(3):155-64. PubMed ID: 16584867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism for virus-induced autoimmunity in humans.
    Nauclér CS; Larsson S; Möller E
    Immunol Rev; 1996 Aug; 152():175-92. PubMed ID: 8930673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of the IgG avidity test in patients with cytomegalovirus disease].
    Lafarga B; Noguera FJ; Bolanos M; Pérez MC; Rodríguez H
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):190-5. PubMed ID: 9312277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD13/aminopeptidase N and murine cytomegalovirus infection.
    Kasman LM
    Virology; 2005 Mar; 334(1):1-9. PubMed ID: 15749117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of autoantibody production associated with cytomegalovirus infection.
    Marshall BC; McPherson RA; Greidinger E; Hoffman R; Adler SP
    Arthritis Res; 2002; 4(5):R6. PubMed ID: 12223109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.
    Rasmussen L; Kelsall D; Nelson R; Carney W; Hirsch M; Winston D; Preiksaitis J; Merigan TC
    J Infect Dis; 1982 Feb; 145(2):191-9. PubMed ID: 6274969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement.
    Middeldorp JM; Jongsma J; The TH
    J Infect Dis; 1986 Jan; 153(1):48-55. PubMed ID: 3001193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
    Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Ikuta K; Kushida N; Yanagida T; Shishido K; Aikawa K; Toma H; Inoue N; Yamaguchi O; Tanabe K; Suzutani T
    Transpl Infect Dis; 2011 Jun; 13(3):318-23. PubMed ID: 20804536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection.
    Tanimura K; Yamada H
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
    Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
    Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report.
    Barzilai O; Sherer Y; Ram M; Izhaky D; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2007 Jun; 1108():567-77. PubMed ID: 17894021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibodies to cytomegalovirus and Epstein-Barr virus in patients with autism spectrum disorder.
    Valayi S; Eftekharian MM; Taheri M; Alikhani MY
    Hum Antibodies; 2017; 26(3):165-169. PubMed ID: 29689713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.